Li Xiaoqiang, Zhang Deli, Bai Yinliang, Xiao Jiyuan, Jiao Haisheng, He Rongxia
Department of Pharmacy, Lanzhou University Second Hospital, Lanzhou 730030, People's Republic of China.
Department of Gynecology, Lanzhou University Second Hospital, Lanzhou 730030, People's Republic of China.
Neuropsychiatr Dis Treat. 2019 Jul 3;15:1813-1822. doi: 10.2147/NDT.S205612. eCollection 2019.
The present study was carried out to confirm the protective effect of extract of (Ginaton) against ischemic neuronal damage post-treatment at 24 h after reperfusion in rats with middle cerebral artery occlusion (MCAO) and further reveal its possible mechanisms.
Adult male Sprague-Dawley rats were modeled by MCAO for 2 h. The rats were divided into three groups: sham, model, and Ginaton (50 mg/kg). All animals received treatment once a day for 14 days from 24 h after reperfusion. Modified neurological severity score test was performed in 1, 7 and 14 days after MCAO, and beam walking test was performed only 14 days after MCAO. Hematoxylin-eosin straining was implemented to measure infarct volume and immunohistochemical analysis was performed to calculate the number of neurons in ischemic cortex penumbra. Western blot was used to evaluate the expression of autophagy (Beclin1, LC3, AMPK, mTOR, ULK), mitochondrial dynamic protein (Parkin, DRP1, OPA1) and apoptosis (Bcl-2, Bax).
Post-treatment with Ginaton for 14 days decreased neurological deficit score, promoted the recovery of motor function, and noticeably reduced infarct size. Besides, Ginaton also alleviated the loss of NeuN-positive cells in ischemic cortex penumbra. In ischemic cortex, Ginaton increased the expression of Beclin1 and LC3-Ⅱ, elevated the AMPK, mTOR and ULK1, and induced autophagy. Moreover, Ginaton treatment upregulated Parkin, DRP1, and OPA1, and elevated the ratio of Bcl-2/Bax in 14 days after MCAO reperfusion injury.
Ginaton exhibited obvious neuroprotective effects in MCAO rats with initial administered 24 h after MCAO. The mechanism of Ginaton included induction of autophagy via activation of the AMPK pathway, maintenance of mitochondrial homeostasis and inhibition of apoptosis.
本研究旨在证实金纳多(Ginaton)提取物对大脑中动脉闭塞(MCAO)大鼠再灌注24小时后缺血性神经元损伤的治疗后保护作用,并进一步揭示其可能的机制。
成年雄性Sprague-Dawley大鼠采用MCAO建模2小时。将大鼠分为三组:假手术组、模型组和金纳多组(50mg/kg)。所有动物在再灌注24小时后每天接受一次治疗,共14天。在MCAO后1、7和14天进行改良神经功能缺损评分测试,仅在MCAO后14天进行横梁行走测试。采用苏木精-伊红染色测量梗死体积,并进行免疫组化分析以计算缺血皮质半暗带中的神经元数量。采用蛋白质免疫印迹法评估自噬(Beclin1、LC3、AMPK、mTOR、ULK)、线粒体动态蛋白(Parkin、DRP1、OPA1)和凋亡(Bcl-2、Bax)的表达。
金纳多治疗14天后可降低神经功能缺损评分,促进运动功能恢复,并显著减小梗死面积。此外,金纳多还减轻了缺血皮质半暗带中NeuN阳性细胞的丢失。在缺血皮质中,金纳多增加了Beclin1和LC3-Ⅱ的表达,升高了AMPK、mTOR和ULK1,并诱导了自噬。此外,金纳多治疗上调了Parkin、DRP1和OPA1,并在MCAO再灌注损伤后14天提高了Bcl-2/Bax的比值。
金纳多对MCAO后24小时开始给药的大鼠具有明显的神经保护作用。金纳多的作用机制包括通过激活AMPK途径诱导自噬、维持线粒体稳态和抑制细胞凋亡。